Stampacchia Otello
- SEC CIK
- 0001361712
No open-market purchases or sales filed in the past year.
Current role at each company
- IMA ImageneBio, Inc.Directoras of Jun 18, 2026
- LXEO Lexeo Therapeutics, Inc.10% Owneras of Nov 9, 2023
- KRON Kronos Bio, Inc.Directoras of Jun 29, 2022
- REPL Replimune Group, Inc.10% Owneras of Mar 16, 2022
- THRX Theseus Pharmaceuticals, Inc.Other: Former 10% owneras of Oct 14, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Stampacchia Otello as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMA ImageneBio, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2025 (view filing) | Jul 25 | 5 daysLate | Stampacchia OtelloDirector | PPurchase | +267.6K | $29.90 | +$8.00M | +142.8%455.0K after |
LXEO Lexeo Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 9, 2023 (view filing)8:36 PM ET | Nov 7 | 2 days | Stampacchia Otello and 5 others10% Owner | PPurchase | +454.5K | $11.00 | +$5.00M | +26.7%2.16M after |
REPL Replimune Group, Inc.
10% Owner11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 (view filing)9:54 PM ET | Mar 14 | 2 days | Stampacchia Otello and 3 others10% Owner | SSale | −16.5K | $15.42 | −$254.4K | −0.3%4.76M after | |
| Mar 16, 2022 (view filing)9:54 PM ET | Mar 15-16 | 1 day | Stampacchia Otello and 3 others10% Owner | SSale | −90.0K | $15.58 | −$1.40M | −1.9%4.67M after | 3 lots |
| Nov 23, 2021 (view filing)4:53 PM ET | Nov 19-22 | 4 days | Stampacchia Otello and 3 othersDirector | SSale | −45.4K | $34.58 | −$1.57M | −0.9%4.76M after | 3 lots |
| Nov 18, 2021 (view filing)6:30 PM ET | Nov 16-18 | 2 days | Stampacchia Otello and 3 othersDirector | SSale | −2.59K | $33.50 | −$86.9K | −0.1%4.81M after | 2 lotsDuplicate filing |
| Nov 18, 2021 (view filing)6:30 PM ET | Nov 16-18 | 2 days | Stampacchia Otello and 3 othersDirector | SSale | −2.59K | $33.50 | −$86.9K | −0.1%4.81M after | 2 lots |
| Nov 16, 2021 (view filing)1:29 PM ET | Nov 12-15 | 4 days | Stampacchia Otello and 3 othersDirector | SSale | −24.0K | $33.66 | −$808.4K | −0.5%4.81M after | 2 lots |
| Nov 12, 2021 (view filing)1:08 PM ET | Nov 10-11 | 2 days | Stampacchia Otello and 3 othersDirector | SSale | −18.3K | $33.61 | −$614.7K | −0.4%4.84M after | 2 lots |
| Nov 10, 2021 (view filing)12:16 PM ET | Nov 8-9 | 2 days | Stampacchia Otello and 3 othersDirector | SSale | −11.4K | $33.66 | −$382.2K | −0.2%4.85M after | 2 lots |
| Nov 8, 2021 (view filing)2:14 PM ET | Nov 4-5 | 4 days | Stampacchia Otello and 3 othersDirector | SSale | −31.0K | $33.57 | −$1.04M | −0.6%4.87M after | 2 lots |
| Sep 27, 2021 (view filing)8:50 PM ET | Sep 23 | 4 days | Stampacchia Otello and 3 othersDirector, 10% Owner | SSale | −12.2K | $33.58 | −$408.7K | −0.2%4.90M after |
THRX Theseus Pharmaceuticals, Inc.
Other: Former 10% owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2021 (view filing)4:40 PM ET | Oct 12 | 2 days | Stampacchia Otello and 4 othersOther: Former 10% owner | PPurchase | +187.5K | $16.00 | +$3.00M | +35.8%711.5K after |